The Fight Malaria Blog
  • About
  • Malaria Minute
  • Interviews
  • Hot Topics
  • Quiz
  • Contact

Research & Development

Interviews with Malaria Stakeholders

Topics:

All,   Academia,   Africa,   Charity,   Diagnosis,   Drug Safety,   Education,   Entrepreneurship,   Equality,   Funding,   Larvicides,   Medicine,   Mosquito Nets,   New Technologies,   Politics,   Research & Development

Hot Topics

The World’s First Malaria Vaccine

An interview with Dr Ashley Birkett, Director of PATH’s Malaria Vaccine Initiative. We discuss RTS,S and the global health challenges surrounding it, in terms of vaccine adherence and hesitancy.

By Thomas Locke, 3 years23rd February 2020 ago
Five Minutes

Transgenic Malaria Control Kills 99% of Mosquitoes in African Trial

A new study has found that fungus, genetically enhanced to produce spider toxin, can kill a large-number of malaria-carrying mosquitos. I speak with Brian Lovett, who is one of the authors of the paper.

By Thomas Locke, 4 years1st June 2019 ago
Five Minutes

Enhancing Mosquito Genome Assembly with a Low-Input DNA Protocol

Creating reference genomes for mosquitos is a challenge. But now, in a partnership between the Sanger Institute and PacBio, it can be made with just 100 nanograms of DNA.

By Thomas Locke, 4 years4th March 2019 ago
Five Minutes

The Programme Analyst Coordinating ‘Bucket Trials’ in India

I’m joined by Lukyn Gedge who is coordinating the Microbide Bucket Challenge in India. Her team is testing the efficacy of a new biodegradable larvicide that can kill mosquitos, releasing carbon dioxide and water into the atmosphere.

By Thomas Locke, 4 years9th December 2018 ago
Five Minutes

The Scientist Developing a New Biodegradable Larvicide

Microbide is developing a biodegradable insecticide for the control of mosquitoes. It’s currently undergoing so-called ‘bucket trials’ in India.

By Thomas Locke, 4 years2nd December 2018 ago
Five Minutes

Five Minutes with Dr Deborah O’Neil | The Post-Antibiotic Era

Dr Deborah O’Neil is the CEO of Novabiotics, a leading clinical-stage biotechnology company. She talks to me about antibiotic resistance and the future of pharma with so-called ‘personalised medicines’.

By Thomas Locke, 4 years14th October 2018 ago
Five Minutes

Five Minutes with Professor Steve Lindsay | Mosquito Nets

Live from Durham University, I speak with Professor Steve Lindsay. His research in developing a new type of mosquito net has hit the headlines, being described as ‘revolutionary’, with the potential to save hundreds of thousands of lives.

By Thomas Locke, 4 years22nd August 2018 ago
Five Minutes

Five Minutes with Dr Michelle Wykes | The Immune System’s Response to Malaria

Dr Michelle Wykes runs the Molecular Immunology unit at QIMR Berghofer Medical Research Institute and has been focusing on trying to improve the immune system’s response to a malaria infection. We discuss her recent work in malaria research which has been hailed as a breakthrough.

By Thomas Locke, 4 years12th August 2018 ago
Five Minutes

Five Minutes with Professor Jake Baum | Malaria Researcher

We speak with Professor Jake Baum of Imperial College London. He has been thrust in the spotlight for what the ‘Independent’ is calling a ‘major malaria breakthrough’. His team is working on trying to find a set of compounds that stop mosquitoes from contracting malaria when they bite an infected person.

By Thomas Locke, 5 years15th July 2018 ago

 

 

We assimilate malaria research and communicate key findings in podcast form.

Along the way, we interview scientists and decision-makers from around the world.

Learn More


News

Contact

Uptime Status

Distilling the science of malaria

We assimilate malaria research and communicate key findings in podcast form.

Along the way, we interview scientists and decision-makers from around the world.

About

News

Contact

Legal

Terms of Use

Privacy Policy

Cookie Policy

Change Cookie Preferences

 

Uptime Status

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Hestia | Developed by ThemeIsle